Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells
BACKGROUND.: CD4Foxp3 regulatory T cells (Treg) depend on interleukin (IL)-2 for their function and survival. By interfering with the IL-2 production, calcineurin inhibitors (CNI) may negatively affect Treg. Here, we describe the effects of conversion from CNI to mycophenolate mofetil (MMF) monotherapy on renal function, and on Treg frequency and phenotype in liver transplant recipients. METHODS.: Patients (=16) with renal impairment on CNI were converted to MMF and received a single dose of IL-2-receptor blocking antibody (Daclizumab). Control patients (=8) continued CNI treatment. RESULTS.: Renal function rapidly and significantly improved after conversion. Daclizumab treatment resulted in a 75% blocking of CD25 at 1 month causing a significant reduction in the percentage of CD4CD25 cells but not affecting the percentage of CD4CD25Foxp3 cells. Six months after conversion to MMF, the percentage of CD4CD25Foxp3 cells increased significantly by 125%. FOXP3 mRNA analysis of mononuclear cells confirmed the enrichment of Foxp3 in peripheral blood. Interestingly, the CD25 expression level on CD4Foxp3, but not CD4Foxp3, cells significantly increased compared with preconversion. CONCLUSION.: Conversion to MMF increases the percentage and CD25 expression of CD4Foxp3 cells indicating that MMF therapy can overturn the repressive effect of CNI on circulating Treg levels and therefore may promote Treg-mediated suppression of alloreactivity.
|Keywords||CD4 antigen, Cyclosporine A, FOXP3 protein, MMF, Nephrotoxicity, Renal function, Tacrolimus, aged, article, calcineurin, classification, creatinine, drug derivative, female, follow up, forkhead transcription factor, human, immunology, immunosuppressive agent, immunosuppressive treatment, interleukin 2 receptor alpha, kidney function test, leukocyte antigen, liver disease, liver function test, liver transplantation, male, metabolism, methodology, middle aged, mycophenolic acid, mycophenolic acid 2 morpholinoethyl ester, physiology, regulatory T lymphocyte, urea nitrogen blood level|
|Persistent URL||dx.doi.org/10.1097/TP.0b013e31819d2032, hdl.handle.net/1765/16420|
Demerkiran, A, Sewgobind, V.D.K.D, van der Weijde, J, Kok, A, Baan, C.C, Kwekkeboom, J, … van der Laan, L.J.W. (2009). Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells. Transplantation, 87(7), 1062–1068. doi:10.1097/TP.0b013e31819d2032